Historique
![Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_73979.webp?v=1771274737)
Article de Périodique
Legalizing a market for cannabis for pleasure: Colorado, Washington, Uruguay and beyond [For debate] (2014)
Auteur(s) :
ROOM, R.
Année
2014
Page(s) :
345-351
Langue(s) :
Anglais
Refs biblio. :
45
Domaine :
Drogues illicites / Illicit drugs
Discipline :
LOI (Loi et son application / Law enforcement)
Thésaurus géographique
ETATS-UNIS
;
URUGUAY
Thésaurus mots-clés
CANNABIS
;
LEGALISATION
;
ALCOOL
;
TABAC
;
PROHIBITION
;
MARCHE DE LA DROGUE
;
TRAITE INTERNATIONAL
Note générale :
Commentaries:
- The powerful mix of capital and cannabis culture. Pedersen W., p. 352-353.
- The difficulty of restricting promotion of legalized marijuana in the United States. Reuter P., p. 353-354.
- New regulated markets for recreational cannabis: public health or private profit? Lenton S., p. 354-355.
- Treaties (probably) not an impediment to ‘legal’ cannabis in Washington and Colorado. Hawken A., Kulick J., p. 355-356.
- Some critical issues in cannabis policy reform. Uchtenhagen A., p. 356-358.
- Cannabis legalization and public health: legal niceties, commercialization and countercultures. Room R., p. 358-359.
- The powerful mix of capital and cannabis culture. Pedersen W., p. 352-353.
- The difficulty of restricting promotion of legalized marijuana in the United States. Reuter P., p. 353-354.
- New regulated markets for recreational cannabis: public health or private profit? Lenton S., p. 354-355.
- Treaties (probably) not an impediment to ‘legal’ cannabis in Washington and Colorado. Hawken A., Kulick J., p. 355-356.
- Some critical issues in cannabis policy reform. Uchtenhagen A., p. 356-358.
- Cannabis legalization and public health: legal niceties, commercialization and countercultures. Room R., p. 358-359.
Résumé :
Colorado, Washington state and Uruguay are currently designing legal non-medical markets for cannabis. These clearly contravene the 1961 and 1988 drug conventions; options for what may happen next are discussed. The current provisions in the three regulatory schemes are summarized. From a public health perspective, the emphasis should be on holding down consumption with regulatory measures, but the public health agenda does not seem to be a strong consideration in the implementation of the US schemes, and they are paying little attention to what can be learned from the history of alcohol and tobacco regulation. While alternative paths to a cannabis market under the conventions are noted, the legalization initiatives underline the need to revise the drug conventions, making prohibition of domestic markets an optional matter. Such changes would also ease the path for including alcohol under the conventions, which would be an important step forward in global health.
Affiliation :
Centre for Alcohol Policy Research, Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
Cote :
Abonnement